SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

22nd Century Group (XXII)

XXII RSS Feed
Add XXII Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, Tamtam, gilbe, esad1, 2014shelby
Search This Board: 
Last Post: 3/24/2017 5:48:40 PM - Followers: 327 - Board type: Free - Posts Today: 12

 

http://images.investorshub.advfn.com/images/converted/635585528992044209.png


http://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/04/brand-A-web-217x300.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/05/brand-B-web-217x300.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2011/05/Spectrum-web21.jpghttp://www.xxiicentury.com/xxii2015/wp-content/uploads/2015/03/Moonlight-packs.jpg



Ticker: XXII (NYSE MKT)
Latest Share Structure:
O/S - 76,009,960 (from 10-k)

Website       SEC Results      Recent News      Major Holders      Analyst Reports     Company Info/Contact

                                                                           22nd Century Group:                                                  Red Sun Cigarettes:      
                                                                                                                                                                                                                    
                                                                                                         
22nd Century is a plant biotechnology company with an important mission: To Reduce the Harm Caused by Smoking.

Our long-term focus is the research, development, licensing, manufacturing, and worldwide sales and distribution of our important products. 22nd Century Group’s proprietary genetic engineering technology and plant breeding expertise allow us to regulate the level of nicotine (and other nicotinic alkaloids) in the tobacco plant. As a result of our unique technology, we are able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as plants with relatively high nicotine levels. The applications for this technology are extraordinary; in independent clinical studies, our very low nicotine (VLN) tobacco has demonstrated remarkable efficacy as a smoking cessation aid. On the other hand, for smokers who do not wish to quit, our high nicotine tobacco enables us to produce a cigarette with what we believe is the world’s lowest tar-to-nicotine ratio.

We believe that the tobacco industry is at the beginning of a paradigm shift toward the development and commercialization of reduced-risk tobacco products which represent a significant step toward achieving the public health objective of harm reduction. Our 18 years of research and development on the tobacco plant, mainly on the nicotine biosynthetic pathway, uniquely positions us to become a major benefactor of this paradigm shift developing in the tobacco industry. Our technology has created, and will continue to develop, a pipeline of products.

We are primarily involved in the following activities:

The international licensing of 22nd Century Ltd’s technology, proprietary tobaccos, and trademarks;
The research and development of potentially reduced-risk or modified risk tobacco products;
The development of X-22, a prescription-based smoking cessation aid consisting of very low nicotine cigarettes;
The manufacture, marketing and international distribution of RED SUN and MAGIC proprietary cigarettes;
The production of SPECTRUM research cigarettes for the National Institute of Drug Abuse (NIDA); and
The contract manufacturing of other companies’ branded tobacco products.

Protecting our technology are 200 issued patents in 96 countries plus over 50 additional pending patent applications. Goodrich Tobacco Company, LLC, Botanical Genetics, Nasco Products, LLC, and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century Group.

Quick Research Links:

 Microcap Research Reports
Bionap, Inc.


XXII Current Stock Chart:

 

                   All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
XXII
Current Price
Volume:
Bid Ask Day's Range
SureTrader
XXII News: 22nd Century Produces Zero THC Industrial Hemp at Anandia Labs 03/23/2017 09:45:00 AM
XXII News: Confidential Treatment Order (ct Order) 03/22/2017 09:41:40 AM
XXII News: 22nd Century Group Issues Annual Letter to Shareholders 03/21/2017 09:50:00 AM
XXII News: Proxy Statement (definitive) (def 14a) 03/17/2017 03:18:02 PM
XXII News: 22nd Century Group Files 2016 Annual Report and Announces Conference Call to Provide Business Update 03/08/2017 04:29:00 PM
PostSubject
#31769  Sticky Note Summary Below: Court rejected Crede’s motion for preliminary injunctive Zedster 06/29/16 11:12:33 AM
#34628   Off DEA web site.DEA Clarifies Status of Hemp Ocean Man 03/24/17 05:56:22 PM
#34627   Totally agree with you!!! Ocean Man 03/24/17 05:48:40 PM
#34626   IMO thats where we take some fear out. Ocean Man 03/24/17 05:47:13 PM
#34625   Depends on who you're talking about. Indoor versus The Lost Trader 03/24/17 10:25:54 AM
#34624   Just a thought, isn't cannabis more expensive per fitter 03/24/17 10:21:04 AM
#34623   Farming is not a winning game. There's a The Lost Trader 03/24/17 10:07:56 AM
#34622   Only thing that matters is a deal...The FDA esad1 03/24/17 10:03:31 AM
#34621   LOL. Ya, June is the real date to Grape Ape 03/24/17 10:01:17 AM
#34620   Wes needs to come back. I think fitter 03/24/17 09:48:18 AM
#34619   It would be nice to know but feel Lnp30 03/24/17 09:39:25 AM
#34618   Agree. Range bound is probably best way to chemist72 03/24/17 08:48:09 AM
#34617   Another question is what is typically the percentage Reeves 03/24/17 08:13:52 AM
#34616   Has anyone come across info on likelihood and/or Scottwny 03/23/17 08:14:59 PM
#34615   Hey I'll take it! God knows every fitter 03/23/17 08:06:52 PM
#34614   Wow. Good news at XXII and only 8.3% 2014shelby 03/23/17 07:40:16 PM
#34613   Basic range bound until news....90-110...above the 200 day esad1 03/23/17 05:02:03 PM
#34612   Chart-wise I see possible support around $1. Would chemist72 03/23/17 03:11:43 PM
#34611   Tech wise above the 200 day moving average esad1 03/23/17 02:50:27 PM
#34610   Too early for deals imo. Sounds like they chemist72 03/23/17 02:45:43 PM
#34609   No need to say much here. This sxdcfv 03/23/17 02:12:32 PM
#34608   Knew it. Licensing deal coming. sgunderbarth 03/23/17 01:56:57 PM
#34607   Hey Monsanto, did you see XXII's press release? Niagara 03/23/17 01:55:27 PM
#34606   22nd Century announces further medical marijuana and industrial Ocean Man 03/23/17 10:01:32 AM
#34605   Agree with your last sentence... A lock on Lnp30 03/23/17 09:14:57 AM
#34604   XXII asked the SEC to grant confidential treatment Ocean Man 03/23/17 08:11:29 AM
#34603   And your the one who thought people smoked Lnp30 03/22/17 06:08:11 PM
#34602   This is a micro cap which you have esad1 03/22/17 06:04:34 PM
#34601   Someone mentioned it had to do with the Lnp30 03/22/17 05:33:59 PM
#34600   Thanks for clarifying. I figured it wasn't Reeves 03/22/17 01:48:06 PM
#34599   This looks like it's related to patents based gilbe 03/22/17 01:38:39 PM
#34598   Your big hang up is you think VLN Lnp30 03/22/17 01:08:33 PM
#34597   Bullish trend, support levels around .80 Bullish3892 03/22/17 12:53:55 PM
#34596   BREAKING DOWN 'Confidential Treatment Order - CTO' Companies would Reeves 03/22/17 11:23:14 AM
#34595   LOL bababooyah 03/22/17 10:14:35 AM
#34594   Henry has said a lot of things and esad1 03/22/17 09:44:24 AM
#34593   Well that would go against a lot of Lnp30 03/22/17 09:11:49 AM
#34592   https://www.washingtonpost.com/news/to-your-health/wp/2017/03/21/tobacco-leaders esad1 03/22/17 09:08:11 AM
#34591   I read the letter. Nothing new but the esad1 03/22/17 07:55:29 AM
#34590   I don't know about you guys but IMO Lnp30 03/22/17 07:39:10 AM
#34589   But let's give management raises and more stock options. bababooyah 03/22/17 07:37:41 AM
#34588   Ya I know he said $10k profit. Just 2014shelby 03/22/17 03:50:27 AM
#34587   Lnp30 said a profit to him of $10K Batermere 03/21/17 10:01:54 PM
#34586   I'd like to see XXII make a major 2014shelby 03/21/17 09:50:03 PM
#34583   BAT - heat not burn. Waiting...waiting. I know Lnp30 03/21/17 02:38:40 PM
#34582   One licensing deal and boom. sgunderbarth 03/21/17 12:03:24 PM
#34581   A regurgitation of a PR sounds like a Lnp30 03/21/17 10:15:38 AM
#34580   Up .09 to 1.04. Sounds BULLISH to me. BOOYAH!!! Batermere 03/21/17 10:02:08 AM
#34577   mgmt is all talk.... absolutely NOT-BUYING-IN-IT 03/21/17 08:24:34 AM
#34576   First, the dilution here has more than doubled NOT-BUYING-IN-IT 03/21/17 08:23:01 AM
#34571   They continue to to take more and more bababooyah 03/20/17 07:54:29 AM
PostSubject